Suppr超能文献

血液透析对终末期肾病患者呼吸困难及肺功能的影响

Impact of hemodialysis on dyspnea and lung function in end stage kidney disease patients.

作者信息

Palamidas Anastasios F, Gennimata Sofia-Antiopi, Karakontaki Foteini, Kaltsakas Georgios, Papantoniou Ioannis, Koutsoukou Antonia, Milic-Emili Joseph, Vlahakos Demetrios V, Koulouris Nikolaos G

机构信息

Respiratory Function Laboratory, 1st Respiratory Medicine Department, Athens University Medical School, "Sotiria" Hospital, 152 Mesogeion Avenue, Athens 11527, Greece.

Artificial Kidney Unit, Euromedica Athinaion, Kononos Street 121-123, Vyronas, Attica, 16231 Athens, Greece.

出版信息

Biomed Res Int. 2014;2014:212751. doi: 10.1155/2014/212751. Epub 2014 May 8.

Abstract

BACKGROUND

Respiratory symptoms are usually underestimated in patients with chronic kidney disease undergoing maintenance hemodialysis. Therefore, we set out to investigate the prevalence of patients chronic dyspnea and the relationship of the symptom to lung function indices.

METHODS

Twenty-five clinically stable hemodialysis patients were included. The mMRC dyspnea scale was applied before and after hemodialysis. Spirometry, single breath nitrogen test, arterial blood gases, static maximum inspiratory (P(imax)) and expiratory (P(emax)) muscle pressures, and mouth occlusion pressure (P 0.1) were also measured.

RESULTS

Despite normal spirometry, all patients (100%) reported mild to moderate degree of chronic dyspnea pre which was reduced after hemodialysis. The sole predictor of (Δ) mMRC was the (Δ) P 0.1 (r = 0.71, P < 0.001). The P(imax) was reduced before and correlated with the duration of hemodialysis (r = 0.614, P < 0.001), whilst after the session it was significantly increased (P < 0.001). Finally (Δ) weight was correlated with the (Δ) P(imax) %pred (r = 0.533, P = 0,006) and with the (Δ) CV (%pred) (r = 0.65, P < 0.001).

CONCLUSION

We conclude that dyspnea is the major symptom among the CKD patients that improves after hemodialysis. The neuromechanical dissociation observed probably is one of the major pathophysiologic mechanisms of dyspnea.

摘要

背景

接受维持性血液透析的慢性肾脏病患者的呼吸道症状通常被低估。因此,我们着手调查慢性呼吸困难患者的患病率以及该症状与肺功能指标的关系。

方法

纳入25例临床稳定的血液透析患者。在血液透析前后应用改良英国医学研究委员会(mMRC)呼吸困难量表。还测量了肺活量测定、单次呼吸氮试验、动脉血气、静态最大吸气(P(imax))和呼气(P(emax))肌肉压力以及口腔闭合压(P 0.1)。

结果

尽管肺活量测定正常,但所有患者(100%)均报告有轻度至中度的慢性呼吸困难,血液透析后有所减轻。(Δ)mMRC的唯一预测指标是(Δ)P 0.1(r = 0.71,P < 0.001)。血液透析前P(imax)降低,且与血液透析时间相关(r = 0.614,P < 0.001),而透析后P(imax)显著升高(P < 0.001)。最后,(Δ)体重与(Δ)P(imax)%预测值相关(r = 0.533,P = 0.006),与(Δ)一氧化碳弥散量(%预测值)相关(r = 0.65,P < 0.001)。

结论

我们得出结论,呼吸困难是慢性肾脏病患者的主要症状,血液透析后有所改善。观察到的神经机械分离可能是呼吸困难的主要病理生理机制之一。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf90/4034396/f262d3b638f1/BMRI2014-212751.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验